Search
for
Sort by
Research 421–450 of 1000+
- Polycystic ovary syndrome in adolescents
- Nonclassic 21-hydroxylase deficiency
- Polycystic Ovary Syndrome
- SAT-214 Satoyoshi Syndrome: A Rare Cause of Premature Ovarian Failure
- A Novel Androgen Receptor Gene Mutation in a 46,XY Patient: Complete Androgen Insensitivity Syndrome
- Pediatric adrenocortical carcinoma complicated by uric acid nephrolithiasis: a unique case report
- Precocious Pubarche in a 7-Year-Old Patient. A Case Report
- European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
- Epidemiological study of prostate cancer (EPICAP): a population-based case–control study in France
- Menopause, skin and common dermatoses. Part 2: skin disorders
- Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
- Acne: Transient Arrest in the Homeostatic Host–Microbiota Dialog?
- EFFECTS of SOME CHEMICALS in COSMETIC PRODUCTS on PREGNANT, FETUS and NEWBORN HEALTH
- Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome
- Dermatological aspects of gender affirming medical treatment in transgender and gender diverse people: A systematic review
- Dermatologic care of patients with differences of sex development
- Practical approaches to the use of markers of biochemical hyperandrogenism in women
- Wokeness in Our Practice
- Drugs and Androgenetic Alopecia: What to look out for
- Virilizing adrenocortical oncocytoma in a toddler
- Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets
- Current evaluation of amenorrhea
- Application of multi-omics techniques to androgenetic alopecia: Current status and perspectives
- The Hair Follicle: A Paradoxical Androgen Target Organ
- Androgen receptors and their biology
- Skin manifestations of hyperandrogenism: an update
- 5-α-Reductase type 2 deficiency: is there a genotype-phenotype correlation? A review
- Hair loss is an important symptom of the menopause
- Treatment guidelines in adult women
- Pediatric Endocrine-Disrupting Chemical Exposure Produces Irreversible Organizational Injury: Biomarker Evidence Necessitating a Precautionary Public Health Framework